Zentalis Pharmaceuticals, Inc.
ZNTL
$1.77
-$0.04-2.21%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 391.25M | 426.39M | 488.98M | 482.92M | 516.64M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.02M | 13.23M | 14.82M | 13.80M | 11.63M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 400.27M | 439.62M | 503.81M | 496.72M | 528.26M |
|
|
|||||
| Total Current Assets | 400.27M | 439.62M | 503.81M | 496.72M | 528.26M |
| Net Property, Plant & Equipment | 38.42M | 38.81M | 40.41M | 41.74M | 42.58M |
| Long-term Investments | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M |
| Goodwill | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.24M | 9.52M | 9.53M | 9.50M | 11.14M |
| Total Assets | 450.66M | 491.68M | 557.48M | 551.69M | 585.72M |
|
|
|||||
| Total Accounts Payable | 8.20M | 20.44M | 10.50M | 14.93M | 14.26M |
| Total Accrued Expenses | 43.71M | 43.12M | 41.15M | 51.54M | 42.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.81M | 2.71M | 2.74M | 2.62M | 2.43M |
| Total Finance Division Other Current Liabilities | 152.00K | 425.00K | 403.00K | 281.00K | -- |
| Total Other Current Liabilities | 152.00K | 425.00K | 403.00K | 281.00K | -- |
| Total Current Liabilities | 54.88M | 66.69M | 54.80M | 69.37M | 58.92M |
|
|
|||||
| Total Current Liabilities | 54.88M | 66.69M | 54.80M | 69.37M | 58.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 40.46M | 41.32M | 42.62M | 43.15M | 43.27M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 996.00K | 1.09M | 1.29M | 1.78M | 1.63M |
| Total Liabilities | 96.33M | 109.10M | 98.71M | 114.30M | 103.82M |
|
|
|||||
| Common Stock & APIC | 1.36B | 1.35B | 1.34B | 1.32B | 1.31B |
| Retained Earnings | -1.01B | -966.77M | -878.49M | -888.56M | -827.64M |
| Treasury Stock & Other | 1.59M | 140.00K | 773.00K | 2.19M | -359.00K |
| Total Common Equity | 354.33M | 382.58M | 458.77M | 437.28M | 481.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 354.33M | 382.58M | 458.77M | 437.28M | 481.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | 107.00K | 129.00K |
| Total Equity | 354.33M | 382.58M | 458.77M | 437.39M | 481.90M |
|
|
|||||
